Novartis AG Common Stock (NVS)

Income Tax Expense

$2.78B

TTM · Period ending: · USD

NVS logo

NVS Income Tax Expense

Latest reported$2.78B
NVS TTM Income Tax ($247.00M → $2.78B)
High-resolution chart · PNG

NVS income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
2,775,632,000
2,269,938,000
2,384,938,000
2,036,000,000
1,970,000,000
2,058,000,000
1,701,000,000
975,000,000
814,000,000
622,000,000
551,000,000
1,087,000,000
1,305,000,000
1,249,000,000
1,329,000,000
1,699,000,000
1,914,000,000
2,178,000,000
2,119,000,000
1,934,000,000
1,940,000,000
1,750,000,000
1,807,000,000
1,977,000,000
1,865,000,000
1,969,000,000
1,793,000,000
1,233,000,000
1,236,000,000
1,154,000,000
1,252,000,000
1,507,000,000
1,491,000,000
1,384,000,000
1,296,000,000
1,113,000,000
1,089,000,000
1,060,000,000
1,119,000,000
1,054,000,000
1,082,000,000
1,075,000,000
1,106,000,000
1,337,000,000
1,410,000,000
1,534,000,000
1,545,000,000
1,501,000,000
1,400,000,000
1,423,000,000
1,457,000,000
1,541,000,000
1,576,000,000
1,589,000,000
1,562,000,000
1,265,000,000
1,321,000,000
1,381,000,000
1,528,000,000
1,632,000,000
1,687,000,000
1,688,000,000
1,733,000,000
1,947,000,000
1,851,000,000
1,729,000,000
1,468,000,000
1,351,000,000
1,310,000,000
1,249,000,000
1,336,000,000
1,338,000,000
1,037,000,000
981,000,000
947,000,000
921,000,000
1,155,000,000
1,190,000,000
1,189,000,000
1,207,000,000
1,241,000,000
1,216,000,000
1,124,000,000
1,102,000,000
1,114,000,000
1,143,000,000
1,126,000,000
1,150,000,000
1,104,000,000
1,053,000,000
1,008,000,000
1,095,000,000
1,053,000,000
1,048,000,000
829,000,000
494,000,000
265,000,000
214,000,000
214,000,000
214,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.